To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FAM195BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
277 supporting clones for gene FAM195B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BM047642 carcinoma, cell line, Prostate .a 1 to 736 1 to 736 N144K S146R tiling clone,   736/736
(100 %)
16 diff
(97.9 %id)
BC094876 Prostate, carcinoma .a 2 to 1039 1 to 1038   tiling clone, AAA   1038/1038
(100 %)
0 diff
(100 %id)
BQ944273 carcinoma, cell line, Prostate .a 3 to 839 1 to 839       839/909
(92 %)
5 diff
(99.5 %id)
BQ958103 carcinoma, cell line, Prostate .a 3 to 903 1 to 912       912/986
(92 %)
18 diff
(98.2 %id)
BQ953008 carcinoma, cell line, Prostate .a 39 to 530 1 to 492       492/1232
(39 %)
22 diff
(98.3 %id)
N54015 multiple sclerosis lesions .a 82 to 244 1 to 163       163/163
(100 %)
0 diff
(100 %id)
BE408178 choriocarcinoma, placenta .b 1 to 614 1 to 612 exact tiling clone,   612/615
(99 %)
3 diff
(99.6 %id)
AI674207 Prostate .c 1 to 596 388 to 21   tiling clone, AAA Suspected internal deletion 368/368
(100 %)
4 diff
(99.0 %id)
BG830426 epithelioid carcinoma cell line, Pancreas .d 1 to 621 1 to 620 Q89R V90C P91R G92V G93A ... tiling clone,   620/621
(99 %)
5 diff
(99.2 %id)
NM_207368.3   .d 5 to 1230 1 to 1226   RefSeq, AAA   1226/1226
(100 %)
0 diff
(100 %id)
TI_57219190   .d 16 to 750 61 to 790       730/912
(80 %)
17 diff
(98.2 %id)
TI_57220299   .d 16 to 847 31 to 872       842/872
(96 %)
46 diff
(94.8 %id)
BX359387 Placenta Cot 25-normalized .d 17 to 920 1 to 899       899/1001
(89 %)
10 diff
(99.1 %id)
CX873241 embryonic stem .d 18 to 729 1 to 712       712/712
(100 %)
0 diff
(100 %id)
AK000852 adipose tissue .d 19 to 1230 1 to 1212   tiling clone, available from FLJ, AAA   1212/1212
(100 %)
3 diff
(99.8 %id)
CN396028 embryonic stem cells, DMSO-treated H9 cellline .d 19 to 616 1 to 598       598/598
(100 %)
0 diff
(100 %id)
CX872239 embryonic stem .d 19 to 835 1 to 817       817/817
(100 %)
2 diff
(99.8 %id)
BG748479 eye, normal pigmented retinal epithelium .d 20 to 622 1 to 603       603/605
(99 %)
2 diff
(99.7 %id)
AL582852 B cells from Burkitt lymphoma .d 21 to 624 1 to 589   fully sequenced,   589/589
(100 %)
0 diff
(100 %id)
BE903422 choriocarcinoma, placenta .d 21 to 871 18 to 864       845/904
(93 %)
25 diff
(97.3 %id)
BI752510 brain .d 21 to 750 1 to 725       725/847
(85 %)
11 diff
(98.8 %id)
BI756452 brain .d 21 to 847 1 to 837       837/837
(100 %)
42 diff
(95.0 %id)
BF530717 anaplastic oligodendroglioma with 1p/19qloss, brain .d 23 to 561 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
BM828953 stomach .d 25 to 565 8 to 548       541/541
(100 %)
0 diff
(100 %id)
BG437400 large cell carcinoma, lung .d 27 to 887 1 to 857       857/890
(96 %)
40 diff
(95.6 %id)
AW248121 lung, small cell carcinoma .d 28 to 498 10 to 480       471/480
(98 %)
6 diff
(98.8 %id)
AW247098 lung, small cell carcinoma .d 28 to 537 10 to 519   available from MGC,   510/519
(98 %)
6 diff
(98.9 %id)
BC019318 Lung, small cell carcinoma .d 28 to 1230 1 to 1203   tiling clone, available from MGC, AAA   1203/1203
(100 %)
0 diff
(100 %id)
BF347862 anaplastic oligodendroglioma with 1p/19qloss, brain .d 28 to 625 1 to 616       616/841
(73 %)
25 diff
(97.1 %id)
BI457480 epithelioid carcinoma cell line, Pancreas .d 28 to 616 1 to 600       600/600
(100 %)
22 diff
(96.4 %id)
TI_45133736   .d 28 to 616 62 to 661       600/600
(100 %)
22 diff
(96.4 %id)
TI_59380882   .d 29 to 861 76 to 920       845/979
(86 %)
39 diff
(96.1 %id)
BG614897 embryonal carcinoma, testis .d 30 to 515 1 to 492       492/842
(58 %)
12 diff
(98.6 %id)
BQ051306 large cell carcinoma, lung .d 30 to 585 1 to 559       559/1214
(46 %)
14 diff
(98.9 %id)
BQ670023 epidermoid carcinoma, cell line, salivary gland .d 31 to 802 1 to 781       781/852
(91 %)
18 diff
(97.9 %id)
BQ668811 epidermoid carcinoma, cell line, salivary gland .d 31 to 760 1 to 728       728/986
(73 %)
23 diff
(97.7 %id)
BQ674120 epidermoid carcinoma, cell line, salivary gland .d 31 to 909 1 to 899       899/900
(99 %)
51 diff
(94.4 %id)
BC063557 Brain, anaplastic oligodendroglioma with1p/19q loss .d 32 to 1230 1 to 1199   available from MGC, AAA   1199/1199
(100 %)
0 diff
(100 %id)
BG910720 anaplastic oligodendroglioma with 1p/19qloss, brain .d 33 to 590 1 to 560   available from MGC,   560/834
(67 %)
8 diff
(99.1 %id)
BG820558 anaplastic oligodendroglioma with 1p/19qloss, brain .d 35 to 757 1 to 713       713/714
(99 %)
25 diff
(96.5 %id)
CN396034 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 36 to 672 1 to 637       637/637
(100 %)
4 diff
(99.4 %id)
BU538447 adenocarcinoma, cell line, breast .d 36 to 965 1 to 946       946/962
(98 %)
29 diff
(97.0 %id)
BF347951 anaplastic oligodendroglioma with 1p/19qloss, brain .d 37 to 616 1 to 583       583/584
(99 %)
11 diff
(98.2 %id)
CT002458 T-Lymphocytes .d 38 to 615 1 to 578       578/579
(99 %)
1 diff
(99.9 %id)
TI_57217545   .d 39 to 679 27 to 660       634/660
(96 %)
8 diff
(98.8 %id)
TI_57151118   .d 39 to 745 33 to 753       721/873
(82 %)
23 diff
(97.4 %id)
TI_57178130   .d 39 to 726 35 to 720       686/721
(95 %)
17 diff
(97.7 %id)
CN396025 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 40 to 556 9 to 525       517/525
(98 %)
6 diff
(98.9 %id)
BI770199 pooled lung and spleen .d 40 to 726 1 to 685       685/686
(99 %)
17 diff
(97.6 %id)
CR998673 T-Lymphocytes .d 41 to 742 1 to 705       705/707
(99 %)
4 diff
(99.5 %id)
CN396036 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 42 to 677 1 to 635       635/635
(100 %)
2 diff
(99.7 %id)
BU147021 brain, neuroblastoma, cell line .d 42 to 957 1 to 931       931/931
(100 %)
21 diff
(97.8 %id)
CD675087 eye, lens .d 43 to 578 1 to 536       536/536
(100 %)
0 diff
(100 %id)
BM721499 eye, fetal eye .d 43 to 489 1 to 447       447/447
(100 %)
0 diff
(100 %id)
CA407204 adipose .d 44 to 540 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
TI_151707627   .d 44 to 643 26 to 632     Submitted on the opposite strand 607/1045
(58 %)
26 diff
(97.6 %id)
CN396032 embryonic stem cells, cell lines H1, H7, andH9 .d 45 to 616 12 to 583       572/583
(98 %)
6 diff
(99.0 %id)
BE396560 Burkitt lymphoma, lymph .d 45 to 636 1 to 589       589/592
(99 %)
7 diff
(98.9 %id)
BE397198 Burkitt lymphoma, lymph .d 45 to 641 1 to 595       595/597
(99 %)
18 diff
(97.0 %id)
BU790061 Pancreas, Purified pancreatic islet .d 45 to 646 1 to 602     Submitted on the opposite strand 602/602
(100 %)
0 diff
(100 %id)
BQ709004 Spleen .d 45 to 850 1 to 818       818/938
(87 %)
17 diff
(98.2 %id)
DR157542 human embryonic stem cells differentiated toan early endodermal cell type .d 45 to 794 1 to 750       750/750
(100 %)
0 diff
(100 %id)
DR761684 embryonic stem .d 45 to 827 1 to 783       783/783
(100 %)
2 diff
(99.8 %id)
BF530866 anaplastic oligodendroglioma with 1p/19qloss, brain .d 46 to 659 4 to 619       616/915
(67 %)
16 diff
(98.3 %id)
BM926909 brain .d 46 to 734 1 to 701       701/1108
(63 %)
26 diff
(97.7 %id)
TI_59387274   .d 46 to 607 57 to 621       565/640
(88 %)
16 diff
(97.5 %id)
BM017030 astrocytoma grade IV, cell line, brain .d 47 to 607 1 to 564       564/639
(88 %)
16 diff
(97.5 %id)
AA036847 uterus .d 48 to 528 1 to 489       489/489
(100 %)
9 diff
(98.2 %id)
BM910602 astrocytoma grade IV, cell line, brain .d 49 to 896 1 to 862       862/1094
(78 %)
20 diff
(98.2 %id)
CN396023 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 50 to 560 3 to 513       511/513
(99 %)
0 diff
(100 %id)
BG339908 leiomyosarcoma cell line, uterus .d 51 to 642 2 to 592       591/1217
(48 %)
8 diff
(99.4 %id)
TI_154189373   .d 53 to 929 47 to 913       867/1012
(85 %)
18 diff
(98.3 %id)
BI836834 pooled pancreas and spleen .d 54 to 793 1 to 754       754/966
(78 %)
29 diff
(97.0 %id)
CA406066 adipose .d 55 to 589 1 to 536       536/536
(100 %)
3 diff
(99.5 %id)
CF126391 Chondrosarcoma Lung Metastasis cell lines, lung .d 55 to 798 1 to 743       743/754
(98 %)
3 diff
(99.7 %id)
BF973045 leiomyosarcoma cell line, uterus .d 57 to 620 8 to 578       573/755
(75 %)
35 diff
(95.4 %id)
BQ427561 eye, retinoblastoma .d 57 to 802 27 to 785       760/908
(83 %)
23 diff
(97.5 %id)
TI_57164183   .d 57 to 793 88 to 838       753/1050
(71 %)
35 diff
(96.7 %id)
BE396525 Burkitt lymphoma, lymph .d 59 to 619 1 to 561       561/565
(99 %)
4 diff
(99.3 %id)
BE798641 lung, small cell carcinoma .d 59 to 637 1 to 579       579/580
(99 %)
20 diff
(96.6 %id)
BG826642 muscle, rhabdomyosarcoma .d 59 to 615 1 to 555       555/555
(100 %)
3 diff
(99.5 %id)
BM011709 brain, neuroblastoma, cell line .d 59 to 861 1 to 814       814/873
(93 %)
33 diff
(96.3 %id)
BE255607 eye, retinoblastoma .d 60 to 606 1 to 549       549/549
(100 %)
6 diff
(99.0 %id)
BQ436303 large cell carcinoma, lung .d 60 to 788 11 to 752       741/939
(78 %)
46 diff
(95.2 %id)
CN396029 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 62 to 675 1 to 614       614/614
(100 %)
0 diff
(100 %id)
CN396030 embryonic stem cells, cell lines H1, H7, andH9 .d 64 to 604 11 to 551       541/551
(98 %)
6 diff
(99.0 %id)
BE890531 melanotic melanoma, skin .d 68 to 894 1 to 818       818/883
(92 %)
57 diff
(93.6 %id)
BF127842 leiomyosarcoma cell line, uterus .d 70 to 650 1 to 588       588/1121
(52 %)
25 diff
(97.8 %id)
BQ706986 Spleen .d 88 to 640 1 to 551       551/969
(56 %)
16 diff
(98.4 %id)
CN396027 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 97 to 678 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
CN396037 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 97 to 583 1 to 487       487/487
(100 %)
0 diff
(100 %id)
BE297229 muscle, rhabdomyosarcoma .d 99 to 725 1 to 621       620/621
(99 %)
18 diff
(97.2 %id)
BG472916 eye, retinoblastoma .d 114 to 620 1 to 509       509/533
(95 %)
4 diff
(99.3 %id)
BG250240 adenocarcinoma, cell line, Liver .d 150 to 851 1 to 702       702/1046
(67 %)
32 diff
(97.0 %id)
BG752887 eye, normal pigmented retinal epithelium .d 151 to 921 1 to 771       771/771
(100 %)
7 diff
(99.1 %id)
CN396026 embryonic stem cells, cell lines H1, H7, andH9 .d 182 to 714 1 to 532       532/532
(100 %)
2 diff
(99.7 %id)
AL554601 placenta, Placenta Cot 25-normalized .d 208 to 1193 1 to 984   fully sequenced,   984/984
(100 %)
5 diff
(99.5 %id)
CR988722 T-Lymphocytes .d 209 to 615 1 to 408       408/410
(99 %)
2 diff
(99.6 %id)
T08806   .d 227 to 502 1 to 276       276/276
(100 %)
2 diff
(99.3 %id)
AL577243 placenta, Placenta Cot 25-normalized .d 270 to 1195 922 to 1   fully sequenced,   922/922
(100 %)
9 diff
(99.1 %id)
BI083921 epidermoid carcinoma, cell line, salivary gland .d 275 to 626 1 to 358   fully sequenced,   358/358
(100 %)
1 diff
(99.8 %id)
R85328 brain .d 322 to 699 1 to 382       382/389
(98 %)
11 diff
(97.2 %id)
BQ068796 brain, neuroblastoma, cell line .d 328 to 1174 3 to 861       859/982
(87 %)
30 diff
(97.0 %id)
BU160655 melanotic melanoma, skin .d 363 to 1230 1 to 875       875/922
(94 %)
26 diff
(97.2 %id)
BM699186 eye, fetal eyes .d 366 to 809 1 to 444       444/444
(100 %)
0 diff
(100 %id)
BX376959 Neuroblastoma Cot 50-normalized .d 380 to 1198 833 to 5       829/879
(94 %)
0 diff
(100 %id)
TI_149312653   .d 390 to 1230 938 to 113   AAA   826/941
(87 %)
24 diff
(97.5 %id)
BI042572 ovary .d 409 to 762 1 to 355       355/355
(100 %)
17 diff
(95.3 %id)
CD673742 eye, lens .d 409 to 959 1 to 551       551/551
(100 %)
0 diff
(100 %id)
TI_159723018   .d 413 to 1230 890 to 82   AAA   809/959
(84 %)
10 diff
(99.0 %id)
BM545701 ovary (pool of 3) .d 439 to 1230 25 to 818       794/1002
(79 %)
16 diff
(98.5 %id)
BI252367 hepatocellular carcinoma, cell line, Liver .d 440 to 1220 1 to 774   fully sequenced,   774/774
(100 %)
28 diff
(96.4 %id)
BQ674871 epidermoid carcinoma, cell line, salivary gland .d 448 to 1230 1 to 784       784/850
(92 %)
18 diff
(97.9 %id)
BQ278889 adenocarcinoma, cell line, breast .d 452 to 1230 1 to 779       779/786
(99 %)
2 diff
(99.8 %id)
CD368474 Alveolar Macrophage, lung .d 452 to 1230 792 to 19   AAA   774/776
(99 %)
5 diff
(99.4 %id)
BE396179 endometrium, adenocarcinoma cell line, uterus .d 483 to 1104 38 to 657       620/657
(94 %)
6 diff
(99.1 %id)
BM978207 lung .d 555 to 1230 693 to 19   AAA   675/675
(100 %)
5 diff
(99.3 %id)
BU623606 cell lines, Enchondroma .d 555 to 1230 693 to 19   AAA   675/675
(100 %)
1 diff
(99.9 %id)
CA944828 Human Lung Epithelial cells, lung .d 584 to 1230 665 to 19   AAA   647/647
(100 %)
1 diff
(99.9 %id)
H02095 placenta .d 590 to 895 1 to 307       307/307
(100 %)
12 diff
(96.1 %id)
AL561655 B cells from Burkitt lymphoma .d 594 to 1207 623 to 11   fully sequenced,   613/623
(98 %)
3 diff
(99.6 %id)
BI084617 epidermoid carcinoma, cell line, salivary gland .d 596 to 1182 591 to 1   fully sequenced,   591/591
(100 %)
5 diff
(99.2 %id)
BI252819 hepatocellular carcinoma, cell line, Liver .d 598 to 1184 592 to 1   fully sequenced,   592/592
(100 %)
13 diff
(97.9 %id)
AA338600 brain .d 600 to 855 1 to 256       256/256
(100 %)
0 diff
(100 %id)
TI_57178997   .d 609 to 1092 27 to 513       487/513
(94 %)
8 diff
(98.5 %id)
BI772546 pooled lung and spleen .d 614 to 1092 1 to 482       482/482
(100 %)
7 diff
(98.6 %id)
BQ061835 lymph, lymphoma, cell line .d 616 to 1229 1 to 614       614/1063
(57 %)
2 diff
(99.9 %id)
BG336364 choriocarcinoma, placenta .d 624 to 1206 1 to 583       583/790
(73 %)
3 diff
(99.7 %id)
AA339563 brain .d 637 to 796 1 to 159       159/159
(100 %)
2 diff
(98.8 %id)
CK902719 Pancreas, Purified pancreatic islet .d 640 to 1230 610 to 20   AAA   591/591
(100 %)
3 diff
(99.5 %id)
BE733191 choriocarcinoma, placenta .d 648 to 1178 1 to 529       529/529
(100 %)
4 diff
(99.3 %id)
BE876770 large cell carcinoma, undifferentiated, lung .d 654 to 1230 1 to 574   AAA   574/574
(100 %)
3 diff
(99.5 %id)
BE621499 epithelioid carcinoma, Pancreas .d 660 to 1230 1 to 572       572/573
(99 %)
19 diff
(96.7 %id)
CN396031 embryonic stem cells, DMSO-treated H9 cellline .d 683 to 1230 1 to 548   AAA   548/548
(100 %)
0 diff
(100 %id)
AA379699 skin .d 694 to 957 1 to 264       264/264
(100 %)
5 diff
(98.2 %id)
CD367844 Alveolar Macrophage, lung .d 701 to 1230 548 to 19   AAA   530/531
(99 %)
1 diff
(99.9 %id)
BP397622 pancreatic islet .d 703 to 1230 1 to 528     Submitted on the opposite strand 528/528
(100 %)
4 diff
(99.3 %id)
TI_151715684   .d 708 to 1230 698 to 173   AAA   526/1090
(48 %)
0 diff
(100 %id)
BU629914 cell lines, Chondrosarcoma .d 715 to 1230 534 to 19   AAA   516/516
(100 %)
0 diff
(100 %id)
CN396035 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 721 to 1205 10 to 494       485/494
(98 %)
6 diff
(98.8 %id)
BQ433942 melanotic melanoma, skin .d 723 to 1230 17 to 524       508/559
(90 %)
5 diff
(99.2 %id)
CA309699 Alveolar Macrophage, lung .d 724 to 1230 522 to 16   AAA   507/507
(100 %)
1 diff
(99.9 %id)
CA424673 cell lines, Chondrosarcoma .d 731 to 1230 518 to 19   AAA   500/500
(100 %)
1 diff
(99.8 %id)
CA424684 cell lines, Chondrosarcoma .d 731 to 1230 519 to 19   AAA   501/501
(100 %)
2 diff
(99.7 %id)
BM546193 ovary (pool of 3) .d 734 to 1222 11 to 515   AAA   505/515
(98 %)
5 diff
(99.1 %id)
AA036786.
matches multiple genes
uterus .d 746 to 1230 496 to 6     also hits gene NCK2 491/497
(98 %)
0 diff
(100 %id)
N52160 multiple sclerosis lesions .d 747 to 1230 485 to 1       485/499
(97 %)
18 diff
(96.4 %id)
AA928059 pooled .d 749 to 1230 489 to 9       481/489
(98 %)
0 diff
(100 %id)
CN396033 embryonic stem cells, DMSO-treated H9 cellline .d 755 to 1230 1 to 476   AAA   476/476
(100 %)
3 diff
(99.4 %id)
AI129422 uterus .d 756 to 1230 476 to 2       475/476
(99 %)
0 diff
(100 %id)
AI869274 anaplastic oligodendroglioma, brain .d 757 to 1230 498 to 25   AAA   474/474
(100 %)
0 diff
(100 %id)
BM906490 ovary (pool of 3) .d 757 to 1230 1 to 474   AAA   474/474
(100 %)
1 diff
(99.8 %id)
BP397266 pancreatic islet .d 767 to 1230 1 to 464     Submitted on the opposite strand 464/467
(99 %)
3 diff
(99.4 %id)
BU790360 Pancreas, Purified pancreatic islet .d 768 to 1230 500 to 38   AAA Submitted on the opposite strand 463/463
(100 %)
7 diff
(98.5 %id)
AI418476 pooled .d 772 to 1230 470 to 12   AAA   459/459
(100 %)
1 diff
(99.8 %id)
AI148445   .d 777 to 1230 458 to 5       454/458
(99 %)
0 diff
(100 %id)
BE295067 muscle, rhabdomyosarcoma .d 777 to 1230 1 to 454   AAA   454/454
(100 %)
0 diff
(100 %id)
AI745663 ovary, tumor, 5 pooled (see description) .d 778 to 1230 461 to 9       453/461
(98 %)
0 diff
(100 %id)
AI745664 ovary, tumor, 5 pooled (see description) .d 778 to 1230 461 to 9       453/461
(98 %)
0 diff
(100 %id)
AI750094 colon .d 778 to 1230 454 to 1       454/454
(100 %)
3 diff
(99.4 %id)
BE674794 B-cell, chronic lymphotic leukemia .d 778 to 1230 469 to 17   AAA   453/453
(100 %)
4 diff
(99.2 %id)
AI636774 pooled germ cell tumors .d 779 to 1230 459 to 8       452/459
(98 %)
0 diff
(100 %id)
AI951659 fibrotheoma, ovary .d 779 to 1230 466 to 15   AAA   452/452
(100 %)
3 diff
(99.4 %id)
AA502914 colon .d 780 to 1230 457 to 8       450/457
(98 %)
0 diff
(100 %id)
AI332558 lung .d 780 to 1230 460 to 10       451/460
(98 %)
0 diff
(100 %id)
AW249782 lung, small cell carcinoma .d 786 to 1230 455 to 11   AAA   445/445
(100 %)
1 diff
(99.8 %id)
BM677137 eye, fetal eye .d 789 to 1230 460 to 19   AAA   442/442
(100 %)
0 diff
(100 %id)
AI569754 anaplastic oligodendroglioma, brain .d 812 to 1230 444 to 26   AAA   419/419
(100 %)
0 diff
(100 %id)
BE905128 epithelioid carcinoma, Pancreas .d 824 to 1230 1 to 406   AAA   406/406
(100 %)
1 diff
(99.8 %id)
AI346060 adenocarcinoma, colon .d 832 to 1230 399 to 1       399/401
(99 %)
0 diff
(100 %id)
R88980 brain .d 841 to 1229 1 to 385   AAA   385/385
(100 %)
20 diff
(94.9 %id)
AI688999 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 841 to 1234 394 to 1       394/394
(100 %)
1 diff
(99.8 %id)
BF031561 hypernephroma, Kidney .d 843 to 1226 1 to 386       386/618
(62 %)
6 diff
(99.1 %id)
BE336921 adenocarcinoma cell line, ovary .d 850 to 1205 1 to 356       356/356
(100 %)
1 diff
(99.8 %id)
R88982 brain .d 853 to 1181 1 to 324       324/324
(100 %)
6 diff
(98.2 %id)
AI283881 adenocarcinoma, colon .d 857 to 1230 374 to 1       374/374
(100 %)
0 diff
(100 %id)
BG988631 head_neck .d 861 to 1213 355 to 3       353/355
(99 %)
0 diff
(100 %id)
AI560699 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 877 to 1230 390 to 36   AAA   355/355
(100 %)
0 diff
(100 %id)
BF688165 eye, normal pigmented retinal epithelium .d 877 to 1230 1 to 355       355/1089
(32 %)
2 diff
(99.9 %id)
N35971 melanocyte .d 895 to 1230 355 to 16   AAA   340/340
(100 %)
20 diff
(94.2 %id)
AA028009 uterus .d 917 to 1230 313 to 1       313/317
(98 %)
5 diff
(98.5 %id)
BE831904 marrow .d 941 to 1286 12 to 364       353/364
(96 %)
6 diff
(98.4 %id)
AI373004 anaplastic oligodendroglioma, brain .d 942 to 1230 322 to 34   AAA   289/296
(97 %)
0 diff
(100 %id)
BU587895 mixed (pool of 40 RNAs) .d 976 to 1226 1 to 251       251/287
(87 %)
2 diff
(99.4 %id)
R85329 brain .d 1001 to 1208 207 to 1       207/207
(100 %)
1 diff
(99.6 %id)
CR983106 T-Lymphocytes .d 1001 to 1230 1 to 230   AAA   230/230
(100 %)
0 diff
(100 %id)
AW198214 adenocarcinoma, Pancreas .d 1008 to 1230 233 to 11   AAA   223/223
(100 %)
0 diff
(100 %id)
R44384 whole brain .d 1049 to 1230 199 to 17   AAA   183/183
(100 %)
5 diff
(97.3 %id)
AI611311 pooled germ cell tumors .d 1052 to 1230 188 to 10       179/188
(95 %)
0 diff
(100 %id)
AW051216 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1052 to 1230 202 to 24   AAA   179/179
(100 %)
0 diff
(100 %id)
AI652736 pooled germ cell tumors .d 1054 to 1230 186 to 10       177/186
(95 %)
0 diff
(100 %id)
AI629018 Kidney .d 1073 to 1230 184 to 27   AAA   158/158
(100 %)
0 diff
(100 %id)
BU787647 insulinoma, Pancreas .d 1076 to 1192 117 to 1       117/123
(95 %)
1 diff
(99.2 %id)
BU787922 insulinoma, Pancreas .d 1076 to 1230 8 to 162       155/162
(95 %)
6 diff
(96.3 %id)
CK826354 insulinoma, Pancreas .d 1076 to 1230 8 to 162       155/162
(95 %)
6 diff
(96.3 %id)
BX649156 human uterus endothel primary cell culture .e 1 to 926 1 to 926 exact tiling clone, available from DKFZ, AAA   926/926
(100 %)
1 diff
(99.9 %id)
NM_001093767.1   .e 2 to 926 1 to 925 exact RefSeq, AAA   925/925
(100 %)
0 diff
(100 %id)
CN402310 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 7 to 582 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
CN402308 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 13 to 783 1 to 771       771/771
(100 %)
2 diff
(99.8 %id)
BG766426 melanotic melanoma, high MDR (cell line), skin .e 17 to 779 1 to 766       766/767
(99 %)
17 diff
(97.8 %id)
BG897411 cartilage .e 19 to 369 86 to 437       352/373
(94 %)
12 diff
(96.8 %id)
BQ694375 adipose .e 19 to 603 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
DR158772 human embryonic stem cells differentiated toan early endodermal cell type .e 20 to 736 1 to 717       717/717
(100 %)
1 diff
(99.9 %id)
BU155435 adenocarcinoma, Pancreas .e 21 to 771 1 to 759       759/913
(83 %)
11 diff
(98.8 %id)
CD386792 embryonic trophoblasts, made from WA01 stemcells .e 27 to 858 23 to 871       849/959
(88 %)
35 diff
(96.4 %id)
BG896293 cartilage .e 31 to 327 85 to 381       297/313
(94 %)
6 diff
(98.1 %id)
AA322258 brain, cerebellum .e 33 to 255 1 to 223       223/223
(100 %)
0 diff
(100 %id)
TI_45235687   .e 33 to 567 84 to 636       553/869
(63 %)
36 diff
(95.9 %id)
CR986866 T-Lymphocytes .e 34 to 454 1 to 421       421/423
(99 %)
1 diff
(99.8 %id)
BI517407 pooled colon, kidney, stomach .e 39 to 567 1 to 547       547/780
(70 %)
30 diff
(96.2 %id)
BG281754 melanotic melanoma, skin .e 40 to 712 1 to 673       673/772
(87 %)
13 diff
(98.4 %id)
BG476572 melanotic melanoma, skin .e 40 to 858 1 to 823       823/824
(99 %)
5 diff
(99.4 %id)
CR979188 T-Lymphocytes .e 40 to 649 1 to 610       610/613
(99 %)
1 diff
(99.9 %id)
BE302844 melanotic melanoma, skin .e 42 to 321 1 to 280       280/280
(100 %)
1 diff
(99.7 %id)
BQ233717 epithelioid carcinoma, Pancreas .e 43 to 848 1 to 813       813/923
(88 %)
10 diff
(99.0 %id)
BU191166 melanotic melanoma, cell line, skin .e 45 to 736 1 to 703       703/979
(71 %)
19 diff
(98.1 %id)
BQ947242 epidermoid carcinoma, cell line, lung .e 46 to 899 35 to 907       873/975
(89 %)
54 diff
(94.5 %id)
AA448810   .e 50 to 448 2 to 403       406/403
(100 %)
10 diff
(97.6 %id)
CR980827 T-Lymphocytes .e 50 to 318 7 to 280       278/283
(98 %)
8 diff
(97.2 %id)
BQ431839 melanotic melanoma, skin .e 53 to 846 1 to 806       806/902
(89 %)
17 diff
(98.2 %id)
AI751390 Bone, Hip .e 55 to 321 16 to 283       268/283
(94 %)
7 diff
(97.6 %id)
BE409625 choriocarcinoma, placenta .e 56 to 742 15 to 696       682/759
(89 %)
14 diff
(98.2 %id)
BE385782 melanotic melanoma, skin .e 59 to 645 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
BE409265 choriocarcinoma, placenta .e 59 to 785 1 to 716       716/735
(97 %)
18 diff
(97.6 %id)
BE390064 endometrium, adenocarcinoma cell line, uterus .e 60 to 709 1 to 650       650/651
(99 %)
9 diff
(98.7 %id)
BE407283 choriocarcinoma, placenta .e 60 to 715 1 to 653       653/655
(99 %)
5 diff
(99.3 %id)
BE727861 melanotic melanoma, skin .e 60 to 821 1 to 751       751/751
(100 %)
19 diff
(97.5 %id)
BM728382 eye, fetal eye .e 62 to 466 1 to 406   fully sequenced,   406/406
(100 %)
1 diff
(99.8 %id)
BC041068 Skin, melanoma, amelanotic .e 72 to 926 1 to 855   available from MGC, AAA   855/855
(100 %)
0 diff
(100 %id)
BM912349 amelanotic melanoma, cell line, skin .e 72 to 730 1 to 663   available from MGC,   663/1146
(57 %)
17 diff
(98.6 %id)
CN402309 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 73 to 716 4 to 647       644/647
(99 %)
5 diff
(99.3 %id)
BM913316 amelanotic melanoma, cell line, skin .e 73 to 888 1 to 818       818/1052
(77 %)
10 diff
(99.1 %id)
BM915459 amelanotic melanoma, cell line, skin .e 73 to 877 1 to 816       816/888
(91 %)
18 diff
(98.0 %id)
AA773388 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 80 to 453 1 to 375       375/375
(100 %)
2 diff
(99.5 %id)
AA773845 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 80 to 538 1 to 460       460/460
(100 %)
2 diff
(99.6 %id)
TI_149293636   .e 86 to 926 927 to 87   AAA   841/996
(84 %)
7 diff
(99.3 %id)
R90766 brain .e 87 to 404 1 to 319       319/329
(96 %)
4 diff
(98.8 %id)
BG926628 cartilage .e 98 to 649 107 to 661       555/661
(83 %)
4 diff
(99.4 %id)
AL538078 brain, fetal brain .e 109 to 926 66 to 887   AAA   825/887
(93 %)
10 diff
(98.9 %id)
BX464731 brain, fetal brain .e 109 to 926 72 to 890       822/925
(88 %)
17 diff
(98.2 %id)
BX332022 Neuroblastoma Cot 25-normalized .e 123 to 926 56 to 858       804/867
(92 %)
20 diff
(97.7 %id)
BX329462 Neuroblastoma Cot 25-normalized .e 123 to 923 802 to 1       802/895
(89 %)
22 diff
(97.6 %id)
BE066380 breast .e 125 to 294 169 to 1     Submitted on the opposite strand 169/169
(100 %)
1 diff
(99.5 %id)
BI910774 leukocyte .e 128 to 926 1 to 798       798/806
(99 %)
2 diff
(99.8 %id)
TI_57237525   .e 128 to 926 29 to 826       796/834
(95 %)
8 diff
(99.1 %id)
BU682755 lung .e 208 to 926 737 to 19   AAA   719/719
(100 %)
3 diff
(99.6 %id)
AW998020 breast_normal .e 297 to 404 105 to 1     Submitted on the opposite strand 105/105
(100 %)
4 diff
(96.2 %id)
BM712440 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 302 to 555 1 to 254   AAA   254/275
(92 %)
1 diff
(99.7 %id)
ES315579 occipital scalp hair, skin .e 306 to 399 1 to 94       94/94
(100 %)
0 diff
(100 %id)
BM710298 eye, optic nerve .e 315 to 466 1 to 152   fully sequenced,   152/152
(100 %)
0 diff
(100 %id)
BU622806 cell lines, Enchondroma .e 336 to 925 608 to 19   AAA   590/590
(100 %)
0 diff
(100 %id)
BG982518 colon_normal .e 342 to 631 1 to 290       290/300
(96 %)
5 diff
(98.4 %id)
AA425433   .e 345 to 926 1 to 583   fully sequenced, AAA   583/583
(100 %)
9 diff
(98.5 %id)
BF929765 nervous_tumor .e 372 to 472 1 to 101       101/101
(100 %)
2 diff
(98.1 %id)
BM671726 eye, optic nerve .e 405 to 926 540 to 19   fully sequenced, AAA   522/522
(100 %)
0 diff
(100 %id)
BU742902 eye, fetal eye .e 405 to 926 540 to 19   fully sequenced, AAA   522/522
(100 %)
0 diff
(100 %id)
AA425296   .e 482 to 926 459 to 13   fully sequenced, AAA   447/447
(100 %)
5 diff
(98.9 %id)
AI479893 anaplastic oligodendroglioma, brain .e 838 to 926 111 to 23   AAA   89/89
(100 %)
2 diff
(97.8 %id)
BU154172 eye, retinoblastoma .f 1 to 766 12 to 787 exact tiling clone,   776/919
(84 %)
24 diff
(97.4 %id)
BY797152 eye .g 1 to 572 6 to 577 exact tiling clone,   577/577
(100 %)
0 diff
(100 %id)
DA858577 placenta .h-u 1 to 600 2 to 602 P99S tiling clone, capped   601/601
(100 %)
2 diff
(99.7 %id)
BE781812 eye, retinoblastoma .i 1 to 559 1 to 556 exact tiling clone,   556/948
(58 %)
7 diff
(99.3 %id)
DA854864 placenta .j 1 to 596 2 to 598 E68G K69E V70G N72* tiling clone, capped   597/597
(100 %)
2 diff
(99.7 %id)
DA854908 placenta .k 1 to 580 2 to 581   tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
BC111795 PCR rescued clones .k 34 to 2549 1 to 2516   tiling clone,   2516/2516
(100 %)
1 diff
(100.0 %id)
BG004043 placenta_normal .k 48 to 649 11 to 603       593/680
(87 %)
6 diff
(99.2 %id)
CB140356 Liver .l 1 to 430 1 to 430 exact tiling clone,   430/430
(100 %)
1 diff
(99.8 %id)
CF456539 peripheral nervous system .l 9 to 803 25 to 806       782/895
(87 %)
23 diff
(97.5 %id)
BQ230873 epithelioid carcinoma, Pancreas .l 25 to 755 1 to 746       746/934
(79 %)
24 diff
(97.5 %id)
BU188846 melanotic melanoma, skin .l 29 to 778 10 to 764       755/880
(85 %)
20 diff
(97.8 %id)
BM555191 duodenal adenocarcinoma, cell line, small intestine .l 68 to 621 22 to 578       557/1340
(41 %)
34 diff
(97.5 %id)
BM559989 amelanotic melanoma, cell line, skin .l 148 to 226 1 to 79       919/1133
(81 %)
36 diff
(96.9 %id)
BM914779 amelanotic melanoma, cell line, skin .l 149 to 926 1 to 786   tiling clone,   786/1130
(69 %)
14 diff
(98.8 %id)
BQ718348 sympathetic trunk .m 1 to 720 1 to 723   tiling clone,   723/928
(77 %)
17 diff
(98.2 %id)
CN396024 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .m 3 to 652 1 to 650   tiling clone,   650/650
(100 %)
0 diff
(100 %id)
BM840633 lymph node, stomach Gene FAM195B, variant not shown         Suspected internal deletion, this clone was ignored    
BM762817 lymph node, stomach Gene FAM195B, variant not shown         Suspected internal deletion, this clone was ignored    
AK125584 small intestine Gene FAM195B, variant not shown       available from FLJ, This clone was ignored    
BX282444   Gene FAM195B, variant not shown         Suspected internal deletion, this clone was ignored    
AA452011   Gene FAM195B, variant not shown         Suspected internal deletion, this clone was ignored    
AI656574 pooled germ cell tumors Gene FAM195B, variant not shown       AAA Suspected internal deletion, internal priming: the 3' end of the oligo dt primed clone lies in the CDS, this clone was ignored    
AI634064 pooled germ cell tumors Gene FAM195B, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI652487 pooled germ cell tumors Gene FAM195B, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AW071805 anaplastic oligodendroglioma, brain Gene FAM195B, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BC017108 Lymph, Burkitt lymphoma Gene FAM195B, variant not shown       available from MGC, AAA This clone was ignored    
BI761980 pooled colon, kidney, stomach Gene FAM195B, variant not shown         This clone was ignored    
BI754274 brain Gene FAM195B, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j, .k, .l, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C